Circulating Levels of ELABELA Is Inversely Associated with Hepatic Fibrosis of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Shi, Min
Cao, Huimin
Liu, Yuting
Gu, Wensha
Zhang, Hong
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1591-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1591-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease
    Vanjiappan, Sivabal
    Hamide, Abdoul
    Ananthakrishnan, Ramesh
    Periyasamy, Senthilkumar Gandhipuram
    Mehalingam, Vadivelan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (04) : 479 - 482
  • [32] Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
    Meroni, Marica
    Longo, Miriam
    Lombardi, Rosa
    Paolini, Erika
    Macchi, Chiara
    Corsini, Alberto
    Sirtori, Cesare R.
    Fracanzani, Anna Ludovica
    Ruscica, Massimiliano
    Dongiovanni, Paola
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (03) : 535 - 549
  • [33] Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
    Muhammad Adnan
    Abdul Wajid
    Wasif Noor
    Andleeb Batool
    Muhammad Aasim
    Kamran Abbas
    Quratul Ain
    Journal of Genetic Engineering and Biotechnology, 20
  • [34] Interrelation of Nonalcoholic Fatty Liver Disease and Hemodynamic Values in Type 2 Diabetes Mellitus Patients
    Chernyaeva, Anna
    Kravchun, Nonna
    Zemlyanitsyna, Olga
    Chernyavskaya, Iryna
    Dorosh, Helen
    Romanova, Iryna
    Polozova, Lubov
    Dunayeva, Inna
    Karachentsev, Iurii
    DIABETES, 2016, 65 : A121 - A121
  • [35] Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
    Adnan, Muhammad
    Wajid, Abdul
    Noor, Wasif
    Batool, Andleeb
    Aasim, Muhammad
    Abbas, Kamran
    Ain, Quratul
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [36] Role of Canagliflozin in the Evolution of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Tejera-Perez, Cristina
    Sanchez-Bao, Ana
    Soto-Gonzalez, Alfonso
    Bellido-Guerrero, Diego
    DIABETES, 2017, 66 : A346 - A346
  • [37] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
    Muzica, Cristina M.
    Sfarti, Catalin
    Trifan, Anca
    Zenovia, Sebastian
    Cuciureanu, Tudor
    Nastasa, Robert
    Huiban, Laura
    Cojocariu, Camelia
    Singeap, Ana-Maria
    Girleanu, Irina
    Chiriac, Stefan
    Stanciu, Carol
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [38] Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
    Fan, Yanbo
    Xiong, Wei
    Li, Jingjing
    Hu, Aimin
    He, Zhiwei
    Zhang, Jiawen
    Zhou, Guoyun
    Yin, Qiang
    PHARMACEUTICAL BIOLOGY, 2018, 56 (01) : 567 - 572
  • [39] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Xueyang Zhang
    Ran Bai
    Yong Jia
    Junwei Zong
    Yongbo Wang
    Yanan Dong
    International Journal of Diabetes in Developing Countries, 2020, 40 : 491 - 499
  • [40] Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
    Bril, Fernando
    Cusi, Kenneth
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (04) : 765 - +
12345